Some of the material in is restricted to members of the community. By logging in, you may be able to gain additional access to certain collections or items. If you have questions about access or logging in, please use the form on the Contact Page.
Patients using the leukotriene inhibitor montelukast require less frequent use of rescue medication than patients using the long-acting beta-agonist salmeterol. (SOR B, based on a single randomized controlled trial [RCT]). No studies have compared short-acting beta-agonists with either leukotriene inhibitors or long-acting beta-agonists.